FORTICAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fortical, and what generic alternatives are available?
Fortical is a drug marketed by Upsher Smith Labs and is included in one NDA.
The generic ingredient in FORTICAL is calcitonin salmon recombinant. There are fourteen drug master file entries for this compound. Additional details are available on the calcitonin salmon recombinant profile page.
Summary for FORTICAL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 16 |
Clinical Trials: | 1 |
Patent Applications: | 379 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in FORTICAL? | FORTICAL excipients list |
DailyMed Link: | FORTICAL at DailyMed |
Recent Clinical Trials for FORTICAL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yale University | N/A |
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | N/A |
Paragraph IV (Patent) Challenges for FORTICAL
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
FORTICAL | Nasal Spray | calcitonin salmon recombinant | 200 IU/spray | 021406 | 1 | 2006-03-29 |
US Patents and Regulatory Information for FORTICAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upsher Smith Labs | FORTICAL | calcitonin salmon recombinant | SPRAY, METERED;NASAL | 021406-001 | Aug 12, 2005 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FORTICAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Upsher Smith Labs | FORTICAL | calcitonin salmon recombinant | SPRAY, METERED;NASAL | 021406-001 | Aug 12, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
Upsher Smith Labs | FORTICAL | calcitonin salmon recombinant | SPRAY, METERED;NASAL | 021406-001 | Aug 12, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
Upsher Smith Labs | FORTICAL | calcitonin salmon recombinant | SPRAY, METERED;NASAL | 021406-001 | Aug 12, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FORTICAL
See the table below for patents covering FORTICAL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 3660401 | ⤷ Try a Trial | |
China | 1422160 | ⤷ Try a Trial | |
China | 1183965 | ⤷ Try a Trial | |
Australia | 783952 | ⤷ Try a Trial | |
European Patent Office | 1251867 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 0156594 | ⤷ Try a Trial | |
Canada | 2399505 | FORMULATIONS DE CALCITONINE POUR ADMINISTRATION PAR VOIE NASALE (NASAL CALCITONIN FORMULATIONS) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |